Pharma Mix
Pharma Mix is a privately held Egyptian pharmaceutical outsourcing firm providing brand planning, sales force management, and medical marketing services for pharmaceutical principals, managing a 25+ ethical-product portfolio primarily for Amoun Pharmaceuticals across Egypt and select MEA markets.
- Company typePrivate
- Founded1999
- HeadquartersGîza, Egypt
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Pharma Mix does
Pharma Mix (also operating as PharmaMix International, فارماميكس) is a privately held Egyptian pharmaceutical outsourcing and commercialization services company founded in 1999, headquartered at 17 El-Nakheel Street, Mohandessin, Giza. The company was established as a strategic outsourcing partner for Amoun Pharmaceuticals (آمون للأدوية), initially promoting an exclusive portfolio of six ophthalmology products, and has since expanded into a diversified therapeutic portfolio spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, cardiovascular, and nutritional supplement categories. Its core capability is outsourced pharmaceutical commercialization: a specialized medical sales force, physician-engagement platform, and market-access infrastructure that enables pharmaceutical principals to deploy and scale products in Egypt and select regional markets without building their own field operations. The company's product portfolio includes Cortiplex B6 Adult and Pediatric (adrenal cortex extract with pyridoxine injections), Solpadol (zolmitriptan orally disintegrating tablets for migraine), Angioblock and Angioblock Mono (irbesartan-based antihypertensives), Shamsomox (moxifloxacin), Coughsed Paracetamol (suppository), Patadoline (olopatadine ophthalmic), Ivybubble (herbal respiratory syrup), Citra Forte (potassium sodium hydrogen citrate granules), Escitapram (escitalopram), and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (cholecalciferol D3 drops).\n\nPharma Mix generates revenue primarily through managed-services arrangements with pharmaceutical principals, under which it provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management. Annual sales exceeded 680 million EGP as of July 2025, attributable to a managed portfolio of more than 25 ethical products for Amoun Pharmaceuticals. Distribution is handled through Egyptian pharmacy networks and direct field sales via medical representatives, with growing international presence through product registrations in UAE, Oman, and Uganda targeting broader expansion into Africa, GCC, Iraq, and CIS markets. Go-to-market combines enterprise field sales, event-driven engagement at medical conferences and scientific symposia (including the Arab Academy of Pediatrics Congress and Egyptian Urology Association Congress), and community-led training programs for pharmaceutical teams.\n\nThe company entered a strategic partnership with Global Napi (GNP) in 2025 to support international expansion, and operates with a headcount of 51–100 employees. It maintains a presence on LinkedIn, Instagram, and Facebook, and positions itself around ethical, performance-driven promotion, world-class standards, and long-term trust-based partnerships. Pharma Mix's stated vision is to rank among the top 80 pharmaceutical companies in Egypt by 2030 through strong outsourcing portfolios and strategic partnerships. The underlying technology stack is conventional — no proprietary AI, APIs, or platform technology is disclosed — and the moat is built on 25 years of accumulated distribution, regulatory familiarity, and physician relationships in the Egyptian pharmaceutical market rather than on technology differentiation.
Pharma Mix firmographics
Firmographics- Name
- Pharma Mix
- Legal name
- PharmaMix
- Website
- https://pharmamix.org
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Pharma Mix is a privately held Egyptian pharmaceutical outsourcing firm providing brand planning, sales force management, and medical marketing services for pharmaceutical principals, managing a 25+ ethical-product portfolio primarily for Amoun Pharmaceuticals across Egypt and select MEA markets.
- Ownership category
- akta.pro rank
Pharma Mix industry classification
Industry- Product category
- Pharmaceutical Outsourcing and Marketing Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industry
- Healthcare/Pharma Creative Agencies (MPAAAAAJ)
Keywords
Where Pharma Mix is headquartered
LocationHeadquarters
- HQ city
- Gîza
- HQ country
- Egypt
- HQ region
- Africa
Offices1 record
Markets served
Pharma Mix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Supply Chain, Operations
Revenue model
- Pharmaceutical Outsourcing Services: End-to-end outsourcing services for pharmaceutical companies including brand strategy planning, sales force management, medical marketing execution, market access coordination, and product lifecycle management. As of July 2025, annual sales exceeded 680 million EGP.
- Pharmaceutical Product Sales: Sale of proprietary pharmaceutical products across multiple therapeutic categories including ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional supplements. Portfolio expanded from 6 products in 1999 to over 25 ethical products and additional product lines.
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
Pharma Mix product offering
Product offeringCore offering
Pharma Mix is a strategic pharmaceutical outsourcing partner that provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management for pharmaceutical companies in Egypt. Founded in 1999 as a marketing partner for Amoun Pharmaceuticals, the company has expanded to manage a portfolio of 25+ ethical pharmaceutical products and dietary supplements spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional categories, with additional toll manufacturing capabilities and international registrations.
Product overview
Pharma Mix operates as a pharmaceutical outsourcing and marketing services company established in 1999, offering a diversified portfolio of pharmaceutical products and dietary supplements. The product portfolio includes: Cortiplex B6 (Adult and Pediatric) corticosteroid injections, Solpadol migraine treatment, Angioblock and Angioblock Mono hypertension medications, Coughsed Paracetamol for cough relief, Shamsomox anti-microbial agent, Patadoline ophthalmic solution, Iv ybubble respiratory syrup, Citra Forte urinary system support, Escitapram for central nervous system conditions, and dietary supplements Lactobay (lactoferrin with vitamin C) and Daline (vitamin D3). The company organizes products across therapeutic categories including central nervous system, urinary system, respiratory system, ophthalmology, anti-microbial, dietary supplements/vitamins, and pediatric products.
Differentiator
Problem solved
Functional benefit
Products and services
- Cortiplex B6 Adult (كورتيبليكيس بي 6 للبالغين) Corticosteroid extract 100 CDU equivalent to 300mcg hydrocortisone combined with pyridoxine hydrochloride 50mg, formulated as an intramuscular injection solution for adult use.
- Cortiplex B6 Pediatric (كورتيبليكيس بي 6 للأطفال) Adrenal cortex extract 50 CDU equivalent to 150mcg hydrocortisone with pyridoxine hydrochloride 20mg, formulated as an intramuscular injection solution for pediatric use.
- Solpadol (سولبادول) Zolmitriptan 2.5mg and 5mg formulated as orally disintegrating tablets (ODT) for migraine treatment.
- Angioblock (أنجيو بلوك) Fixed-dose combination of irbesartan with hydrochlorothiazide available in three strengths (150/12.5mg, 300/12.5mg, 300/25mg), formulated as film-coated tablets for hypertension management.
- Angioblock Mono (أنجيو بلوك مونو) Irbesartan monotherapy available in 75mg, 150mg, and 300mg tablet formulations for hypertension treatment.
- Coughsed Paracetamol (كوفسيد – باراسيتامول) Combination of gelseomium extract, grindelia extract, and paracetamol formulated as suppositories for cough relief.
- Shamsomox (شمسوموكس) Moxifloxacin 400mg formulated as film-coated tablets, an anti-microbial agent for treating bacterial infections.
- Patadoline (باتادولين) Olopatadine 0.1% ophthalmic solution for eye care, providing relief from allergic eye conditions.
- Ivybubble (ايفاي بابل) Herbal respiratory syrup combining ivy leaf extract (35mg), thyme extract (21.5mg), and licorice extract (21.7mg) per 5ml, supporting respiratory health and relieving cough.
- Citra Forte (سيترافورت) Potassium sodium hydrogen citrate in granule form for urinary system support and alkalization.
- Escitapram (اسيتابرام) Escitalopram 10mg and 20mg tablets for the treatment of central nervous system conditions including depression and anxiety disorders.
- Lactobay (لاكتوباي) Lactoferrin 100mg with vitamin C 40mg in sachet format, supporting immune function and iron absorption.
- Daline (دالين) Cholecalciferol (Vitamin D3) 400 IU per drop in oral drop format, supporting bone health and immune system function, with coconut oil base for enhanced absorption.
Quantifiable outcome
- Annual sales exceeded 680 million EGP as of July 2025
- +2 more outcomes
Companies that use Pharma Mix
Customer profileSegments2 records
Ideal customer profiles2 records
Pharma Mix technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharma Mix partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- Global Napi (GNP)flagshipPharmaMix entered a strategic partnership with Global Napi (GNP) as part of its expansion strategy, with plans to build additional strategic alliances during the upcoming period. This represents a significant partnership for international market expansion.
- Amoun Pharmaceuticals (آمون للأدوية)corePharmaMix was founded in 1999 as a strategic outsourcing partner for Amoun Pharmaceuticals, exclusively promoting a specialized portfolio of ophthalmology products. This partnership established one of the most successful long-term outsourcing models in the local pharmaceutical sector, expanding from 6 products to 25+ ethical products across multiple therapeutic areas. The partnership continues as of July 2025.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
Pharma Mix competitors and assessment
Company assessmentDirect peers
- Eva Pharma: Major Egyptian pharmaceutical manufacturer and marketer with broad therapeutic-area coverage and integrated distribution across Egypt and select MENA/African markets. Directly comparable as an Egypt-anchored pharma company combining manufacturing, marketing and distribution like PharmaMix.
- EIPICO (Egyptian International Pharmaceutical Industries Company): One of Egypt's largest pharmaceutical manufacturers with diversified therapeutic portfolio and established sales force across Egyptian pharmacies. Comparable as a domestically-focused pharma peer competing for the same HCP and pharmacy channel.
- Pharco Pharmaceuticals: Largest Egyptian pharmaceutical company by domestic sales with extensive product portfolio, manufacturing and distribution infrastructure. Closest scale peer in the Egyptian pharma market, similarly combining manufacturing with broad pharmacy-channel commercialization.
- Global Napi Pharmaceuticals (GNP): Egyptian pharma manufacturer that entered a strategic 2025 partnership with PharmaMix. Operates across multiple therapeutic areas and competes for the same outsourced sales/marketing engagements; comparable as both peer and counterparty.
Others
- Amoun Pharmaceuticals: PharmaMix's anchor outsourcing client since 1999 and a major Egyptian pharma manufacturer. Functions as a customer rather than direct competitor, but is structurally the most relevant counterparty shaping PharmaMix's revenue base.
Broad incumbents
- Hikma Pharmaceuticals: Jordan-headquartered global pharma company with significant MENA manufacturing, branded generics and distribution footprint. Comparable as a broader incumbent operating across the same regional markets PharmaMix is targeting.
Regional players
- Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with GCC and emerging-markets distribution. Comparable as a regional peer for PharmaMix's UAE/Oman expansion plans and for its branded-generics + outsourcing-style commercial model.
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Saudi Arabia's largest pharmaceutical manufacturer with regional distribution across MENA. Comparable as a regional peer for PharmaMix's stated GCC expansion and for combining manufacturing with outsourced commercial functions.
- Tabuk Pharmaceuticals: Saudi-based pharma manufacturer with branded generics and MENA distribution footprint, including GCC and selective African markets. Comparable as a regional peer relevant to PharmaMix's stated GCC and Africa expansion.
Emerging players
- Aspen Pharmacare: Africa's largest pharmaceutical manufacturer with broad therapeutic coverage and active distribution across Sub-Saharan and MENA markets. Comparable as a peer relevant to PharmaMix's African expansion roadmap (Uganda registered).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharma Mix social profiles
Digital presencePharma Mix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharma Mix leadership team
Management profileNumber of profiles
Pharma Mix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharma Mix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharma Mix
What does Pharma Mix do?
Pharma Mix is a strategic pharmaceutical outsourcing partner that provides end-to-end brand planning, specialized sales force management, medical and marketing execution, market access coordination, and product lifecycle management for pharmaceutical companies in Egypt. Founded in 1999 as a marketing partner for Amoun Pharmaceuticals, the company has expanded to manage a portfolio of 25+ ethical pharmaceutical products and dietary supplements spanning ophthalmology, anti-microbial, respiratory, urinary, central nervous system, and nutritional categories, with additional toll manufacturing capabilities and international registrations.
Is Pharma Mix a public or private company?
Pharma Mix is a private company. It is classified as unknown and is currently operating.
When was Pharma Mix founded?
Pharma Mix was founded in 1999. It employs 51 to 100 people.
Where is Pharma Mix based?
Pharma Mix is headquartered in Gîza, Egypt, in the Africa region.
How does Pharma Mix make money?
Two revenue lines are on record. Pharmaceutical Outsourcing Services are the primary driver. The others are pharmaceutical Product Sales.
Who are Pharma Mix's main competitors?
Direct peers on record are Eva Pharma, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals and Global Napi Pharmaceuticals (GNP). Amoun Pharmaceuticals is listed as an others. Hikma Pharmaceuticals is listed as a broad incumbent. Regional players are Julphar (Gulf Pharmaceutical Industries), SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) and Tabuk Pharmaceuticals. Aspen Pharmacare is listed as an emerging player.
Does Pharma Mix have an API?
No public API is recorded for Pharma Mix.
What industry is Pharma Mix in?
Pharma Mix's product category is Pharmaceutical Outsourcing and Marketing Services. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 424210 and its SIC code is 5122.